Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study.
Frederik Pagh Bredahl KristensenDiana Hedevang ChristensenBrian Christopher CallaghanJohnny KahlertSøren T KnudsenSøren H SindrupEva L FeldmanLeif ØstergaardHenning AndersenTroels S JensenHenrik T SørensenReimar Wernich ThomsenPublished in: Diabetes care (2020)
Statin therapy is unlikely to increase or mitigate DPN risk in patients with type 2 diabetes, although a small acute risk of harm cannot be excluded.